Publications
-
Clinical outcome prediction by microRNAs in human cancer: a systematic review.
Nair VS,
Maeda LS, Ioannidis JP.
J Natl Cancer Inst.
2012;
104
(7):
528-40
-
Current concepts and controversies in the management of early stage Hodgkin lymphoma.
Maeda LS,
Lee M, Advani RH.
Leuk Lymphoma.
2011;
52
(6):
962-71
-
Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.
Advani RH,
Hoppe RT, Maeda LS, Baer DM, Mason J, Rosenberg SA, Horning SJ.
Int J Radiat Oncol Biol Phys.
2011;
81
(5):
1374-9
-
The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.
Maeda LS,
Advani RH.
Curr Opin Oncol.
2009;
21
(5):
397-400
-
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Advani R,
Maeda L, Lavori P, Quon A, Hoppe R, Breslin S, Rosenberg SA, Horning SJ.
J Clin Oncol.
2007;
25
(25):
3902-7
-
Transcription arrest at an abasic site in the transcribed strand of template DNA.
Tornaletti S,
Maeda LS, Hanawalt PC.
Chem Res Toxicol.
2006;
19
(9):
1215-20
-
Transcriptional inhibition by an oxidized abasic site in DNA.
Wang Y,
Sheppard TL, Tornaletti S, Maeda LS, Hanawalt PC.
Chem Res Toxicol.
2006;
19
(2):
234-41
-
Effect of 8-oxoguanine on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II.
Tornaletti S,
Maeda LS, Kolodner RD, Hanawalt PC.
DNA Repair (Amst).
2004;
3
(5):
483-94
-
Effect of thymine glycol on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II.
Tornaletti S,
Maeda LS, Lloyd DR, Reines D, Hanawalt PC.
J Biol Chem.
2001;
276
(48):
45367-71
Navigation for This Section: Department of Medicine
Find a Researcher
Help